Biomatrix Inc said it has received a Phase II small businessinnovation research grant for $250,000 from the National EyeInstitute to study in vivo response to implanted biopolymers.Biopolymers may be useful as drugs, devices and drug deliverysystems. The Ridgefield, N.J., company develops biomaterialsfor use in orthopedic and ophthalmic applications and skin careproducts.

(c) 1997 American Health Consultants. All rights reserved.